InMed Pharmaceuticals, Inc. (INM)
1.45
+0.02
(+1.40%)
USD |
NASDAQ |
Aug 25, 16:00
1.45
0.00 (0.00%)
After-Hours: 19:59
InMed Pharmaceuticals Total Assets (Quarterly) : 9.134M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 9.134M |
| December 31, 2025 | 11.19M |
| September 30, 2025 | 13.36M |
| June 30, 2025 | 15.58M |
| March 31, 2025 | 9.280M |
| December 31, 2024 | 8.502M |
| September 30, 2024 | 10.47M |
| June 30, 2024 | 11.82M |
| March 31, 2024 | 13.36M |
| December 31, 2023 | 15.26M |
| September 30, 2023 | 10.92M |
| June 30, 2023 | 14.11M |
| March 31, 2023 | 14.73M |
| December 31, 2022 | 16.92M |
| September 30, 2022 | 14.58M |
| June 30, 2022 | 12.79M |
| March 31, 2022 | 15.49M |
| December 31, 2021 | 19.38M |
| September 30, 2021 | 17.33M |
| June 30, 2021 | 9.781M |
| March 31, 2021 | 12.34M |
| December 31, 2020 | 9.221M |
| September 30, 2020 | 6.308M |
| June 30, 2020 | 7.803M |
| March 31, 2020 | 8.399M |
| Date | Value |
|---|---|
| December 31, 2019 | 10.89M |
| September 30, 2019 | 12.74M |
| June 30, 2019 | 15.14M |
| March 31, 2019 | 16.73M |
| December 31, 2018 | 18.04M |
| September 30, 2018 | 20.35M |
| June 30, 2018 | 21.33M |
| March 31, 2018 | 11.89M |
| December 31, 2017 | 11.72M |
| September 30, 2017 | 6.065M |
| June 30, 2017 | 6.419M |
| March 31, 2017 | 3.335M |
| December 31, 2016 | 1.670M |
| September 30, 2016 | 1.266M |
| June 30, 2016 | 1.212M |
| March 31, 2016 | 1.154M |
| December 31, 2015 | 1.095M |
| September 30, 2015 | 1.117M |
| June 30, 2015 | 1.330M |
| March 31, 2015 | 1.218M |
| December 31, 2014 | 1.349M |
| September 30, 2014 | 1.501M |
| June 30, 2014 | 1.592M |
| March 31, 2014 | 0.0062M |
| December 31, 2013 | 0.0036M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NervGen Pharma Corp. | 63.57M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
| Clearmind Medicine, Inc. | 14.52M |
| Lexaria Bioscience Corp. | 4.781M |
| Target Group, Inc. (Canada) | 5.678M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.242M |
| Shareholders Equity (Quarterly) | 6.892M |
| Debt to Equity Ratio | 0.061 |
| Current Ratio | 3.115 |
| Net Debt Paydown Yield | 4.95% |